# Misoprostol Versus Effox as Cervical Ripening Agent Prior Surgical Evacuation

> **NCT02738177** · PHASE2 · UNKNOWN · sponsor: **Cairo University** · enrollment: 90 (estimated)

## Conditions studied

- Cervical Ripening

## Interventions

- **DRUG:** Misoprostol
- **DRUG:** Isosorbide-5-mononitrate
- **DRUG:** misoprostol and Isosorbide-5-mononitrate

## Key facts

- **NCT ID:** NCT02738177
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-11
- **Primary completion:** 2016-06
- **Final completion:** —
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2016-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02738177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02738177, "Misoprostol Versus Effox as Cervical Ripening Agent Prior Surgical Evacuation". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02738177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*